what is bronchitis
Info about bronchitis coughing => bronchitis cures => Topic started by: glennaguilar on August 31, 2016, 11:00:32 am
-
Bronchitis Exacerbation - How is Bronchitis Treated?
Bronchitis is a disease which affects many people and has affected one person at least once in a lifetime. Until now doctors have been prescribing antibiotics for bronchitis but researchers have proven that antibiotics are not so necessary in treating this condition and using them frequently only helps drug resistance to develop.
Case the patient has purulent acute bronchitis, antibiotic treatment is necessary. Tetracycline, erythromycin, amoxicillin and ampicillin are suitable for treating this type of bronchitis as they are active upon the bacteria responsible for producing this disease.
- Besides the drug-based on treatment the patient should know that rest and well hydration are essential for a quick recovery.
- Fever is treated with ASA and acetaminophen.
- Because bronchitis gives cough the patient should take antitussive medication like: chlophedianol, levopropoxyphene, dextromethorphan, and codeine.
- They will act upon the medullary cough center and will suppress the cough reflex.
- In case the patient coughs and has bronchial secretions which have to be expelled the doctor will prescribe expectorants.
- They are decreasing the viscosity of the secretions helping them to be expelled better when coughing.
- In the composition of expectorants iodides, ammonium chloride, terpin hydrate, syrup of ipecac, guaifenesin, and even creosote can be found.
- In some cases acacia, glycerin, honey, or an extract of Prunus can be added to the composition of the expectorant.
- People have an inclination of bragging on the knowledge they have on any particular project.
- However, we don't want to brag on what we know on Bronchitis Antibiotics, so long as it proves useful to you, we are happy.
As every year more than 10 million patients are treated in the emergency room for bronchitis with antibiotics, a group of researchers decided to see whether antibiotics like azithromycin are effective and really useful in treating bronchitis. The study was multicenter, randomized, and double-blind.
Patients who have chronic bronchitis an exacerbation of the symptoms which contain purulent sputum seems to be worse than in those who have mucoid sputum. These symptoms can be managed easily and will disappear by the end of day five if treatment is followed exactly. We have gone through extensive research and reading to produce this article on Chronic Bronchitis Exacerbation. Use the information wisely so that the information will be properly used.
448 patients which presented cough with or without sputum were taken in consideration for this study. From the whole group, 340 were diagnosed with bronchitis, and 220 met the criteria for randomization. In the end189 patients completed the study. From these 189 patients, 97 received 250 mg/day of azithromycin, and 92 received 250 mg/day of vitamin C. Besides these two medications dextromethorphan syrup and an albuterol inhaler were also given to the patients who used them every 6 hours as needed. At 3 and 7 days the cough symptoms and limitations on activity were assessed. At the end of the study the researchers concluded that no statistical differences existed between the two groups. This means that antibiotic treatment is not so necessary for the cases of bronchitis and antitussive medication and beta2-agonists are the only ones who are really worth to be taken along with keeping a good hydration. If you find anything extra mentioning about Acute Bronchitis Chronic Bronchitis, do inform us. It is only through the exchange of views and information will we learn more about Acute Bronchitis Chronic Bronchitis.
The fluoroquinolones are a relatively new group of antibiotics. Fluoroquinolones were first introduced in 1986, but they are really modified quinolones, a class of antibiotics, whose accidental discovery occurred in the early 1960.
Classification of Fluoroquinolones
As a group, the fluoroquinolones have excellent in vitro activity against a wide range of both gram-positive and gram-negative bacteria. The newest fluoroquinolones have enhanced activity against gram-positive bacteria with only a minimal decrease in activity against gram-negative bacteria. Their expanded gram-positive activity is especially important because it includes significant activity against Streptococcus pneumoniae.
Third Generation
The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species. Whenever one reads any reading matter likeBronchitis, it is vital that the person enjoys reading it. One should grasp the meaning of the matter, only then can it be considered that its reading is complete.
Second-generation agents include ciprofloxacin, enoxacin, lomefloxacin, norfloxacin and ofloxacin. Ciprofloxacin is the most potent fluoroquinolone against P. aeruginosa. Ciprofloxacin and ofloxacin are the most widely used second-generation quinolones because of their availability in oral and intravenous formulations and their broad set of FDA-labeled indications.
All of the fluoroquinolones are effective in treating urinary tract infections caused by susceptible organisms. They are the first-line treatment of acute uncomplicated cystitis in patients who cannot tolerate sulfonamides or TMP, who live in geographic areas with known resistance > 10% to 20% to TMP-SMX, or who have risk factors for such resistance.
Urinary tract infections (norfloxacin, lomefloxacin, enoxacin, ofloxacin, ciprofloxacin, levofloxacin, gatifloxacin, trovafloxacin) Lower respiratory tract infections (lomefloxacin, ofloxacin, ciprofloxacin, trovafloxacin) Skin and skin-structure infections (ofloxacin, ciprofloxacin, levofloxacin, trovafloxacin) Urethral and cervical gonococcal infections (norfloxacin, enoxacin, ofloxacin, ciprofloxacin, gatifloxacin, trovafloxacin) Prostatitis (norfloxacin, ofloxacin, trovafloxacin) Acute sinusitis (ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin (Avelox), trovafloxacin) Acute exacerbations of chronic bronchitis (levofloxacin, sparfloxacin (Zagam), gatifloxacin, moxifloxacin, trovafloxacin) Community-acquired pneumonia (levofloxacin, sparfloxacin, gatifloxacin, moxifloxacin, trovafloxacin) Bronchitis proved to be the foundation for the writing of this page. We have used all facts and definitions of Bronchitis to produce worthwhile reading material for you.
Conditions Treated With Fluoroquinolones: Indications and Uses
The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. The serum elimination half-life of the fluoroquinolones range from 3 -20 hours, allowing for once or twice daily dosing. You may be filled with astonishment with the amount of information we have compile here on Chronic Bronchitis. that was our intention, to astonish you.
Fourth Generation
The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
Fluoroquinolones disadvantages: Tendonitis or tendon rupture Multiple drug interactions Not used in children Newer quinolones produce additional toxicities to the heart that were not found with the older agents